|
Market Closed -
Nasdaq
16:00:00 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 11.08 USD | -0.09% |
|
+9.70% | -8.73% |
| 08-18 | Ocular Therapeutix, Inc. - Special Call | |
| 08-04 | Ocular Therapeutix's NDA Plans for Axpaxli in Wet AMD Remain on Track, RBC Says | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- OCUL Stock
- Consensus Ocular Therapeutix, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
